Clinical trials: Ankle Brachial Index

Peripheral Artery Disease, Vascular Disease

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients

• Withdrawn
• Age: 18 to 59 years
• Phase 4
• Pill or oral medicine

The purpose of the study is to assess the effect of blood flow to the heart when subjects are treated with ticagrelor (Brilinta) or clopidogrel (antiplatelet drugs that stop the blood from clumping together) in patients with…

Conditions

Peripheral Artery Disease, Vascular Disease, Arterial Occlusion Disease, Intermittent Claudication

Trial name

PAD (NCT02121288)

Testing

Ticagrelor, clopidogrel

Sponsor

AstraZeneca